Engineering CD16-Enhanced Stem Cell–Derived Universal NKT Cells to Potentiate Anti-CD70 Therapy in Renal Cell Carcinoma

cusatuzumab (ARGX-110) - OncoVerity

Dr. Yan-Ruide Li Ph.D. 1, 2, 3; Mr. Yichen Zhu 1; Ms. Yuning Chen 1; Thomas Yuen 1; Shelby Yeh 1

Jul 22, 2026